Skip to main content
. 2022 Apr 13;17(4):1619–1625. doi: 10.1016/j.jds.2022.03.014

Table 1.

Characteristics of participants.

Osteoporosis/solid cancer Total BP/Dmab users Users of other drugs P value
Patients 92 60 32
(Women) (82) (56) (26)
Osteoporosis medication users 81 Oral BPs 37 21
Injection BPs 11
Dmab 12
a Age (years, mean ± SD) 74.6 ± 10.8 77.5 ± 7.9 68.3 ± 13.4 ∗∗
 Median 76 78 70 3.13E-05
Oral BPs 77.1 ± 8.9
Injection BPs 77.8 ± 4.0
Dmab 78.5 ± 7.9
b Number of extracted teeth 78 70 8 ∗∗
 (Patients) (47) (40) (7) 8.54E-05
 Upper 32 29 3
 Lower 46 41 5
Period of tooth extraction from first visit 96.2 ± 96.4 days 103.8 ± 99.8 days 43.1 ± 42.7 days
 Median 69 89 33
Period of follow-up after tooth extraction 122.7 ± 182.0 days 122.6 ± 170.0 days 123.9 ± 268.7 days
 Median 42 45 28
 MRONJ 11 patients Referral clinic, 9 patients 0
Our clinic, 2 patients (3.3%)

BP, bisphosphonate; Dmab, denosumab; SD, standard deviation; MRONJ, medication-related osteonecrosis of the jaw.

∗∗P < 0.01.

a

Student's t-test.

b

Mann–Whitney U test.